p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Helene VanackerIsabelle TreilleuxCamille SchifflerIvan BiecheMario CamponeAnne PatsourisMonica ArnedosPaul-Henri CottuJean-Philippe JacquinFlorence DalencAntoine PintonNicolas ServantValéry AttignonEtienne RouleauAlain MorelFrançois LegrandMarta JimenezFabrice AndreThomas BachelotPublished in: British journal of cancer (2024)
NCT02444390.